Poor Treatment Outcome of Neuroblastoma and Other Peripheral Nerve Cell Tumors May be Related to Under Usage of Radiotherapy and Socio-Economic Disparity: A US SEER Data Analysis

  • Published : 2012.09.30


Purpose: This study used receiver operating characteristic curve to analyze Surveillance, Epidemiology and End Results (SEER) neuroblastoma (NB) and other peripheral nerve cell tumors (PNCT) outcome data. This study found under usage of radiotherapy in these patients. Materials and methods: This study analyzed socio-economic, staging and treatment factors available in the SEER database for NB and other PNCT. For the risk modeling, each factor was fitted by a generalized linear model to predict the outcome (soft tissue specific death, yes/no). The area under the receiver operating characteristic curve (ROC) was computed. Similar strata were combined to construct the most parsimonious models. A random sampling algorithm was used to estimate the modeling errors. Risk of neuroendocrine (other endocrine including thymus as coded in SEER) death was computed for the predictors. Results: There were 5261 patients diagnosed from 1973 to 2009 were included in this study. The mean follow up time (S.D.) was 83.8 (97.6) months. The mean (SD) age was 18 (25) years. About 30.45% of patients were un-staged. The SEER staging has high ROC (SD) area of 0.58 (0.01) among the factors tested. We simplified the 4-layered risk levels (local, regional, distant, un-staged/others) to a simpler 3-tiered model with comparable ROC area of 0.59 (0.01). Less than 50% of PNCT patients received radiotherapy (RT) including the ones with localized disease. This avoidance of RT use occurred in adults and children. Conclusion: The high under-staging rate may have precented patients from selecting definitive radiotherapy (RT) after surgery. Using RT for, especially, adult PNCT patients is a potential way to improve outcome.


  1. Bassal M, Mertens AC, Taylor L, et al. (2006). Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol, 24, 476-83.
  2. Benoit MM, Bhattacharyya N, Faquin W, Cunningham M (2008). Cancer of the nasal cavity in the pediatric population. Pediatrics, 121, e141-5.
  3. Bhatia S (2011). Disparities in cancer outcomes: lessons learned from children with cancer. Pediatr Blood Cancer, 56, 994-1002.
  4. Cheung R (2012). Using SEER Clinical Outcome Prediction Expert(SCOPE) to mine massive data and construct efficient prognostic models: predicting breast cancer specific survival in Georgia USA. Submitted.
  5. Cheung R, Altschuler MD, D'Amico AV, et al (2001a). ROC-optimization may improve risk stratification of prostate cancer patients. Urology, 57, 286-90.
  6. Cheung R, Altschuler MD, D'Amico AV, et al (2001b). Using the receiver operator characteristic curve to select pretreatment and pathologic predictors for early and late post-prostatectomy PSA failure. Urology, 58, 400-5.
  7. Cohen RJ, Curtis RE, Inskip PD, Fraumeni JF (2005). The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer, 103, 2391-6.
  8. D'Amico AV, Desjardin A, Chung A, et al. (1998). Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer, 82, 1887-96.<1887::AID-CNCR11>3.0.CO;2-P
  9. Esiashvili N, Goodman M, Ward K, et al (2007). Neuroblastoma in adults: incidence and survival analysis based on SEER data. Pediatr Blood Cancer, 49, 41-6.
  10. Friedman DL, Whitton J, Leisenring W, et al (2010). Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst, 102, 1083-95.
  11. Hanley JA, McNeil BJ (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36.
  12. Herzog CE (2005). Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol, 27, 215-8.
  13. Hsieh MH, Meng MV, Walsh TJ, Matthay KK, Baskin LS (2009). Increasing incidence of neuroblastoma and potentially higher associated mortality of children from nonmetropolitan areas: analysis of the surveillance, epidemiology, and end results database. J Pediatr Hematol Oncol, 31, 942-6.
  14. Johnson KA, Aplenc R, Bagatell R (2011). Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005. Pediatr Blood Cancer, 56, 425-31.
  15. Kuhlthau KA, Pulsifer MB, Yeap BY, et al (2012). Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol, 30, 2079-86.
  16. Lacour B, Guyot-Goubin A, Guissou S, et al (2010). Incidence of childhood cancer in France: National Children Cancer Registries, 2000-2004. Eur J Cancer Prev, 19, 173-81.
  17. Miralbell R, Lomax A, Cella L, Schneider U (2002). Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys, 54, 824-9.
  18. Navalkele P, O'Dorisio MS, O'Dorisio TM, et al (2011). Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006. Pediatr Blood Cancer, 56, 50-7.
  19. Pan IJ, Daniels JL, Zhu K (2010). Poverty and childhood cancer incidence in the United States. Cancer Causes Control, 21, 1139-45.
  20. Perme M.P, Jereb B (2009). Trends in survival after childhood cancer in Slovenia between 1957 and 2007. Pediatr Hematol Oncol, 26, 240-51.
  21. Platek ME, Merzianu M, Mashtare TL, et al (2011). Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol, 6, 41.
  22. Pui CH, Pei D, Pappo AS, et al (2012). Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol, 30, 2005-12.
  23. Schultz KA, Ness KK, Whitton J, et al (2007). Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol, 25, 3649-56.
  24. Shapiro NL, Bhattacharyya N (2009). Staging and survival for sinus cancer in the pediatric population. Int J Pediatr Otorhnolaryngol, 73, 1568-71.
  25. StatBite (2011). Neuroblastoma: five-year survival. J Natl Cnacer Inst 103, 1220.

Cited by

  1. Impact of socioeconomic disparities on cause-specific survival of retinoblastoma vol.1, pp.3, 2013,
  2. Lack of Health Insurance Increases All Cause and All Cancer Mortality in Adults: An Analysis of National Health and Nutrition Examination Survey (NHANES III) Data vol.14, pp.4, 2013,
  3. African American Race and Low Income Neighborhoods Decrease Cause Specific Survival of Endometrial Cancer: A SEER Analysis vol.14, pp.4, 2013,
  4. Using SEER Data to Quantify Effects of Low Income Neighborhoods on Cause Specific Survival of Skin Melanoma vol.14, pp.5, 2013,
  5. Analysis of ICU Treatment on Resection of Giant Tumors in the Mediastinum of the Thoracic Cavity vol.14, pp.6, 2013,
  6. Interleukin-24 Induces Neuroblastoma SH-SY5Y Cell Differentiation, Growth Inhibition, and Apoptosis by Promoting ROS Production vol.33, pp.11, 2013,
  7. Adenovirus arming human IL-24 inhibits neuroblastoma cell proliferation in vitro and xenograft tumor growth in vivo vol.34, pp.4, 2013,
  8. Underusage of radiotherapy and a lack of socio-economic disparity in treatment outcome: a population-based study on adenoid cystic carcinomas vol.13, pp.02, 2014,
  9. Socio-economic Factors Affect the Outcome of Soft Tissue Sarcoma: an Analysis of SEER Data vol.15, pp.1, 2014,
  10. Association between Urinary Cadmium and All Cause, All Cancer and Prostate Cancer Specific Mortalities for Men: an Analysis of National Health and Nutrition Examination Survey (NHANES III) Data vol.15, pp.1, 2014,
  11. Optimization of Predictors of Ewing Sarcoma Cause-specific Survival: A Population Study vol.15, pp.10, 2014,
  12. Receiver Operating Characteristic Curve Analysis of SEER Medulloblastoma and Primitive Neuroectodermal Tumor (PNET) Outcome Data: Identification and Optimization of Predictive Models vol.15, pp.16, 2014,
  13. Surveying and Optimizing the Predictors for Ependymoma Specific Survival using SEER Data vol.15, pp.2, 2014,
  14. Expression of Ki-67, p53 and VEGF in Pediatric Neuroblastoma vol.15, pp.7, 2014,
  15. Under-use of Radiotherapy in Stage III Bronchioaveolar Lung Cancer and Socio-economic Disparities in Cause Specific Survival: a Population Study vol.15, pp.9, 2014,